nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Almotriptan—CYP2E1—liver cancer	0.00563	0.4	CrCbGaD
Zolmitriptan—Melatonin—ESR1—liver cancer	0.00469	0.334	CrCbGaD
Zolmitriptan—Melatonin—CYP1A1—liver cancer	0.00375	0.267	CrCbGaD
Zolmitriptan—Cramps of lower extremities—Doxorubicin—liver cancer	0.0023	0.00267	CcSEcCtD
Zolmitriptan—Dyspepsia—Sorafenib—liver cancer	0.0023	0.00267	CcSEcCtD
Zolmitriptan—Oesophagitis—Doxorubicin—liver cancer	0.00229	0.00265	CcSEcCtD
Zolmitriptan—Decreased appetite—Sorafenib—liver cancer	0.00227	0.00263	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Epirubicin—liver cancer	0.00227	0.00263	CcSEcCtD
Zolmitriptan—Ecchymosis—Doxorubicin—liver cancer	0.00227	0.00262	CcSEcCtD
Zolmitriptan—Neoplasm—Doxorubicin—liver cancer	0.00227	0.00262	CcSEcCtD
Zolmitriptan—Bladder pain—Doxorubicin—liver cancer	0.00227	0.00262	CcSEcCtD
Zolmitriptan—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00226	0.00262	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Sorafenib—liver cancer	0.00226	0.00261	CcSEcCtD
Zolmitriptan—Photosensitivity—Epirubicin—liver cancer	0.00224	0.00259	CcSEcCtD
Zolmitriptan—Pain—Sorafenib—liver cancer	0.00224	0.00259	CcSEcCtD
Zolmitriptan—Constipation—Sorafenib—liver cancer	0.00224	0.00259	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Doxorubicin—liver cancer	0.00223	0.00258	CcSEcCtD
Zolmitriptan—Hypertonia—Doxorubicin—liver cancer	0.0022	0.00254	CcSEcCtD
Zolmitriptan—Eczema—Epirubicin—liver cancer	0.00219	0.00253	CcSEcCtD
Zolmitriptan—Eye pain—Epirubicin—liver cancer	0.00218	0.00252	CcSEcCtD
Zolmitriptan—Mental disability—Doxorubicin—liver cancer	0.00218	0.00252	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Sorafenib—liver cancer	0.00214	0.00248	CcSEcCtD
Zolmitriptan—Lymphadenopathy—Doxorubicin—liver cancer	0.00213	0.00247	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Doxorubicin—liver cancer	0.0021	0.00243	CcSEcCtD
Zolmitriptan—Increased appetite—Epirubicin—liver cancer	0.00209	0.00242	CcSEcCtD
Zolmitriptan—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00209	0.00242	CcSEcCtD
Zolmitriptan—Urticaria—Sorafenib—liver cancer	0.00208	0.00241	CcSEcCtD
Zolmitriptan—Photosensitivity—Doxorubicin—liver cancer	0.00207	0.0024	CcSEcCtD
Zolmitriptan—Abdominal pain—Sorafenib—liver cancer	0.00207	0.00239	CcSEcCtD
Zolmitriptan—Body temperature increased—Sorafenib—liver cancer	0.00207	0.00239	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Epirubicin—liver cancer	0.00203	0.00235	CcSEcCtD
Zolmitriptan—Eczema—Doxorubicin—liver cancer	0.00203	0.00234	CcSEcCtD
Zolmitriptan—Eye pain—Doxorubicin—liver cancer	0.00202	0.00233	CcSEcCtD
Zolmitriptan—Diplopia—Epirubicin—liver cancer	0.00197	0.00228	CcSEcCtD
Zolmitriptan—Osteoarthritis—Epirubicin—liver cancer	0.00197	0.00228	CcSEcCtD
Zolmitriptan—Increased appetite—Doxorubicin—liver cancer	0.00194	0.00224	CcSEcCtD
Zolmitriptan—Affect lability—Epirubicin—liver cancer	0.00194	0.00224	CcSEcCtD
Zolmitriptan—Migraine—Epirubicin—liver cancer	0.00194	0.00224	CcSEcCtD
Zolmitriptan—Hypersensitivity—Sorafenib—liver cancer	0.00193	0.00223	CcSEcCtD
Zolmitriptan—Face oedema—Epirubicin—liver cancer	0.0019	0.0022	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00188	0.00218	CcSEcCtD
Zolmitriptan—Asthenia—Sorafenib—liver cancer	0.00188	0.00217	CcSEcCtD
Zolmitriptan—Mood swings—Epirubicin—liver cancer	0.00186	0.00216	CcSEcCtD
Zolmitriptan—Pruritus—Sorafenib—liver cancer	0.00185	0.00214	CcSEcCtD
Zolmitriptan—Ataxia—Epirubicin—liver cancer	0.00185	0.00214	CcSEcCtD
Zolmitriptan—Dehydration—Epirubicin—liver cancer	0.00183	0.00212	CcSEcCtD
Zolmitriptan—Osteoarthritis—Doxorubicin—liver cancer	0.00182	0.00211	CcSEcCtD
Zolmitriptan—Diplopia—Doxorubicin—liver cancer	0.00182	0.00211	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Epirubicin—liver cancer	0.0018	0.00208	CcSEcCtD
Zolmitriptan—Affect lability—Doxorubicin—liver cancer	0.00179	0.00207	CcSEcCtD
Zolmitriptan—Migraine—Doxorubicin—liver cancer	0.00179	0.00207	CcSEcCtD
Zolmitriptan—Diarrhoea—Sorafenib—liver cancer	0.00179	0.00207	CcSEcCtD
Zolmitriptan—Face oedema—Doxorubicin—liver cancer	0.00176	0.00203	CcSEcCtD
Zolmitriptan—Gastritis—Epirubicin—liver cancer	0.00174	0.00202	CcSEcCtD
Zolmitriptan—Muscular weakness—Epirubicin—liver cancer	0.00173	0.00201	CcSEcCtD
Zolmitriptan—Dizziness—Sorafenib—liver cancer	0.00173	0.002	CcSEcCtD
Zolmitriptan—Mood swings—Doxorubicin—liver cancer	0.00172	0.002	CcSEcCtD
Zolmitriptan—Ataxia—Doxorubicin—liver cancer	0.00171	0.00198	CcSEcCtD
Zolmitriptan—Dysphagia—Epirubicin—liver cancer	0.0017	0.00197	CcSEcCtD
Zolmitriptan—Influenza—Epirubicin—liver cancer	0.0017	0.00197	CcSEcCtD
Zolmitriptan—Dehydration—Doxorubicin—liver cancer	0.00169	0.00196	CcSEcCtD
Zolmitriptan—Eosinophilia—Epirubicin—liver cancer	0.00168	0.00195	CcSEcCtD
Zolmitriptan—Pancreatitis—Epirubicin—liver cancer	0.00167	0.00193	CcSEcCtD
Zolmitriptan—Vomiting—Sorafenib—liver cancer	0.00166	0.00193	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Doxorubicin—liver cancer	0.00166	0.00192	CcSEcCtD
Zolmitriptan—Angina pectoris—Epirubicin—liver cancer	0.00166	0.00192	CcSEcCtD
Zolmitriptan—Rash—Sorafenib—liver cancer	0.00165	0.00191	CcSEcCtD
Zolmitriptan—Dermatitis—Sorafenib—liver cancer	0.00165	0.00191	CcSEcCtD
Zolmitriptan—Headache—Sorafenib—liver cancer	0.00164	0.0019	CcSEcCtD
Zolmitriptan—Bronchitis—Epirubicin—liver cancer	0.00163	0.00189	CcSEcCtD
Zolmitriptan—Gastritis—Doxorubicin—liver cancer	0.00161	0.00186	CcSEcCtD
Zolmitriptan—Muscular weakness—Doxorubicin—liver cancer	0.00161	0.00186	CcSEcCtD
Zolmitriptan—Influenza—Doxorubicin—liver cancer	0.00157	0.00182	CcSEcCtD
Zolmitriptan—Dysphagia—Doxorubicin—liver cancer	0.00157	0.00182	CcSEcCtD
Zolmitriptan—Pollakiuria—Epirubicin—liver cancer	0.00157	0.00182	CcSEcCtD
Zolmitriptan—Eosinophilia—Doxorubicin—liver cancer	0.00156	0.0018	CcSEcCtD
Zolmitriptan—Nausea—Sorafenib—liver cancer	0.00155	0.0018	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Epirubicin—liver cancer	0.00155	0.0018	CcSEcCtD
Zolmitriptan—Weight increased—Epirubicin—liver cancer	0.00155	0.00179	CcSEcCtD
Zolmitriptan—Pancreatitis—Doxorubicin—liver cancer	0.00154	0.00179	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Epirubicin—liver cancer	0.00153	0.00178	CcSEcCtD
Zolmitriptan—Angina pectoris—Doxorubicin—liver cancer	0.00153	0.00177	CcSEcCtD
Zolmitriptan—Pneumonia—Epirubicin—liver cancer	0.00152	0.00177	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—liver cancer	0.00151	0.00175	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Epirubicin—liver cancer	0.00149	0.00172	CcSEcCtD
Zolmitriptan—Stomatitis—Epirubicin—liver cancer	0.00148	0.00171	CcSEcCtD
Zolmitriptan—Jaundice—Epirubicin—liver cancer	0.00148	0.00171	CcSEcCtD
Zolmitriptan—Urinary tract infection—Epirubicin—liver cancer	0.00147	0.00171	CcSEcCtD
Zolmitriptan—Conjunctivitis—Epirubicin—liver cancer	0.00147	0.00171	CcSEcCtD
Zolmitriptan—Sweating—Epirubicin—liver cancer	0.00145	0.00168	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—liver cancer	0.00145	0.00168	CcSEcCtD
Zolmitriptan—Haematuria—Epirubicin—liver cancer	0.00145	0.00167	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—liver cancer	0.00144	0.00166	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—liver cancer	0.00143	0.00166	CcSEcCtD
Zolmitriptan—Epistaxis—Epirubicin—liver cancer	0.00143	0.00166	CcSEcCtD
Zolmitriptan—Sinusitis—Epirubicin—liver cancer	0.00142	0.00165	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—liver cancer	0.00142	0.00164	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—liver cancer	0.00141	0.00163	CcSEcCtD
Zolmitriptan—Bradycardia—Epirubicin—liver cancer	0.00139	0.0016	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—liver cancer	0.00137	0.00159	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—liver cancer	0.00137	0.00158	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—liver cancer	0.00137	0.00158	CcSEcCtD
Zolmitriptan—Rhinitis—Epirubicin—liver cancer	0.00136	0.00158	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—liver cancer	0.00136	0.00158	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—liver cancer	0.00136	0.00158	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Epirubicin—liver cancer	0.00135	0.00157	CcSEcCtD
Zolmitriptan—Pharyngitis—Epirubicin—liver cancer	0.00135	0.00156	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—liver cancer	0.00134	0.00156	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Epirubicin—liver cancer	0.00134	0.00156	CcSEcCtD
Zolmitriptan—Oedema peripheral—Epirubicin—liver cancer	0.00134	0.00155	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—liver cancer	0.00134	0.00155	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Epirubicin—liver cancer	0.00134	0.00155	CcSEcCtD
Zolmitriptan—Urethral disorder—Epirubicin—liver cancer	0.00133	0.00154	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—liver cancer	0.00132	0.00153	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—liver cancer	0.00132	0.00152	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—liver cancer	0.00128	0.00148	CcSEcCtD
Zolmitriptan—Tinnitus—Epirubicin—liver cancer	0.00127	0.00147	CcSEcCtD
Zolmitriptan—Cardiac disorder—Epirubicin—liver cancer	0.00126	0.00146	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—liver cancer	0.00126	0.00146	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—liver cancer	0.00125	0.00145	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—liver cancer	0.00125	0.00145	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—liver cancer	0.00124	0.00144	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—liver cancer	0.00124	0.00144	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—liver cancer	0.00124	0.00143	CcSEcCtD
Zolmitriptan—Angiopathy—Epirubicin—liver cancer	0.00123	0.00143	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—liver cancer	0.00123	0.00143	CcSEcCtD
Zolmitriptan—Immune system disorder—Epirubicin—liver cancer	0.00123	0.00142	CcSEcCtD
Zolmitriptan—Chills—Epirubicin—liver cancer	0.00122	0.00141	CcSEcCtD
Zolmitriptan—Arrhythmia—Epirubicin—liver cancer	0.00122	0.00141	CcSEcCtD
Zolmitriptan—Erythema—Epirubicin—liver cancer	0.00118	0.00137	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—liver cancer	0.00117	0.00136	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—liver cancer	0.00117	0.00135	CcSEcCtD
Zolmitriptan—Tension—Epirubicin—liver cancer	0.00116	0.00135	CcSEcCtD
Zolmitriptan—Dysgeusia—Epirubicin—liver cancer	0.00116	0.00134	CcSEcCtD
Zolmitriptan—Nervousness—Epirubicin—liver cancer	0.00115	0.00133	CcSEcCtD
Zolmitriptan—Back pain—Epirubicin—liver cancer	0.00115	0.00133	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—liver cancer	0.00114	0.00132	CcSEcCtD
Zolmitriptan—Muscle spasms—Epirubicin—liver cancer	0.00114	0.00132	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—liver cancer	0.00114	0.00132	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—liver cancer	0.00113	0.00131	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—liver cancer	0.00112	0.0013	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Epirubicin—liver cancer	0.0011	0.00127	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—liver cancer	0.0011	0.00127	CcSEcCtD
Zolmitriptan—Agitation—Epirubicin—liver cancer	0.00109	0.00126	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—liver cancer	0.00108	0.00125	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—liver cancer	0.00107	0.00124	CcSEcCtD
Zolmitriptan—Malaise—Epirubicin—liver cancer	0.00107	0.00124	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—liver cancer	0.00106	0.00123	CcSEcCtD
Zolmitriptan—Vertigo—Epirubicin—liver cancer	0.00106	0.00123	CcSEcCtD
Zolmitriptan—Syncope—Epirubicin—liver cancer	0.00106	0.00123	CcSEcCtD
Zolmitriptan—Leukopenia—Epirubicin—liver cancer	0.00106	0.00123	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—liver cancer	0.00106	0.00123	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—liver cancer	0.00105	0.00122	CcSEcCtD
Zolmitriptan—Palpitations—Epirubicin—liver cancer	0.00105	0.00121	CcSEcCtD
Zolmitriptan—Loss of consciousness—Epirubicin—liver cancer	0.00104	0.00121	CcSEcCtD
Zolmitriptan—Cough—Epirubicin—liver cancer	0.00103	0.0012	CcSEcCtD
Zolmitriptan—Convulsion—Epirubicin—liver cancer	0.00103	0.00119	CcSEcCtD
Zolmitriptan—Hypertension—Epirubicin—liver cancer	0.00102	0.00118	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—liver cancer	0.00102	0.00118	CcSEcCtD
Zolmitriptan—Chest pain—Epirubicin—liver cancer	0.00101	0.00117	CcSEcCtD
Zolmitriptan—Arthralgia—Epirubicin—liver cancer	0.00101	0.00117	CcSEcCtD
Zolmitriptan—Myalgia—Epirubicin—liver cancer	0.00101	0.00117	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—liver cancer	0.00101	0.00117	CcSEcCtD
Zolmitriptan—Anxiety—Epirubicin—liver cancer	0.001	0.00116	CcSEcCtD
Zolmitriptan—Discomfort—Epirubicin—liver cancer	0.000996	0.00115	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—liver cancer	0.000988	0.00114	CcSEcCtD
Zolmitriptan—Dry mouth—Epirubicin—liver cancer	0.000986	0.00114	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—liver cancer	0.000985	0.00114	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—liver cancer	0.000983	0.00114	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—liver cancer	0.000981	0.00114	CcSEcCtD
Zolmitriptan—Confusional state—Epirubicin—liver cancer	0.000975	0.00113	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—liver cancer	0.000969	0.00112	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Epirubicin—liver cancer	0.000967	0.00112	CcSEcCtD
Zolmitriptan—Oedema—Epirubicin—liver cancer	0.000967	0.00112	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—liver cancer	0.000963	0.00112	CcSEcCtD
Zolmitriptan—Infection—Epirubicin—liver cancer	0.00096	0.00111	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—liver cancer	0.000956	0.00111	CcSEcCtD
Zolmitriptan—Shock—Epirubicin—liver cancer	0.000951	0.0011	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—liver cancer	0.00095	0.0011	CcSEcCtD
Zolmitriptan—Nervous system disorder—Epirubicin—liver cancer	0.000948	0.0011	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Epirubicin—liver cancer	0.000947	0.0011	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—liver cancer	0.000946	0.0011	CcSEcCtD
Zolmitriptan—Tachycardia—Epirubicin—liver cancer	0.000944	0.00109	CcSEcCtD
Zolmitriptan—Skin disorder—Epirubicin—liver cancer	0.000939	0.00109	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Epirubicin—liver cancer	0.000935	0.00108	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—liver cancer	0.000933	0.00108	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—liver cancer	0.000933	0.00108	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—liver cancer	0.000933	0.00108	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—liver cancer	0.00093	0.00108	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—liver cancer	0.000922	0.00107	CcSEcCtD
Zolmitriptan—Anorexia—Epirubicin—liver cancer	0.000921	0.00107	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—liver cancer	0.000913	0.00106	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—liver cancer	0.000902	0.00104	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—liver cancer	0.000894	0.00104	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—liver cancer	0.000894	0.00104	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—liver cancer	0.000889	0.00103	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000881	0.00102	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—liver cancer	0.00088	0.00102	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—liver cancer	0.000877	0.00102	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—liver cancer	0.000876	0.00101	CcSEcCtD
Zolmitriptan—Insomnia—Epirubicin—liver cancer	0.000874	0.00101	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—liver cancer	0.000873	0.00101	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—liver cancer	0.000869	0.00101	CcSEcCtD
Zolmitriptan—Paraesthesia—Epirubicin—liver cancer	0.000868	0.001	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—liver cancer	0.000865	0.001	CcSEcCtD
Zolmitriptan—Dyspnoea—Epirubicin—liver cancer	0.000862	0.000998	CcSEcCtD
Zolmitriptan—Somnolence—Epirubicin—liver cancer	0.000859	0.000995	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—liver cancer	0.000853	0.000987	CcSEcCtD
Zolmitriptan—Dyspepsia—Epirubicin—liver cancer	0.000851	0.000985	CcSEcCtD
Zolmitriptan—Decreased appetite—Epirubicin—liver cancer	0.00084	0.000973	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000835	0.000966	CcSEcCtD
Zolmitriptan—Pain—Epirubicin—liver cancer	0.000827	0.000957	CcSEcCtD
Zolmitriptan—Constipation—Epirubicin—liver cancer	0.000827	0.000957	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000815	0.000943	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—liver cancer	0.000809	0.000937	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—liver cancer	0.000803	0.00093	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—liver cancer	0.000797	0.000923	CcSEcCtD
Zolmitriptan—Feeling abnormal—Epirubicin—liver cancer	0.000797	0.000922	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—liver cancer	0.000795	0.000921	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Epirubicin—liver cancer	0.000791	0.000915	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—liver cancer	0.000787	0.000912	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—liver cancer	0.000778	0.0009	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000772	0.000894	CcSEcCtD
Zolmitriptan—Urticaria—Epirubicin—liver cancer	0.000768	0.000889	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—liver cancer	0.000765	0.000886	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—liver cancer	0.000765	0.000886	CcSEcCtD
Zolmitriptan—Abdominal pain—Epirubicin—liver cancer	0.000764	0.000885	CcSEcCtD
Zolmitriptan—Body temperature increased—Epirubicin—liver cancer	0.000764	0.000885	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—liver cancer	0.000737	0.000853	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000731	0.000847	CcSEcCtD
Zolmitriptan—Hypersensitivity—Epirubicin—liver cancer	0.000712	0.000825	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—liver cancer	0.000711	0.000823	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—liver cancer	0.000707	0.000819	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—liver cancer	0.000707	0.000819	CcSEcCtD
Zolmitriptan—Asthenia—Epirubicin—liver cancer	0.000694	0.000803	CcSEcCtD
Zolmitriptan—Pruritus—Epirubicin—liver cancer	0.000684	0.000792	CcSEcCtD
Zolmitriptan—Diarrhoea—Epirubicin—liver cancer	0.000661	0.000766	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—liver cancer	0.000659	0.000763	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—liver cancer	0.000642	0.000743	CcSEcCtD
Zolmitriptan—Dizziness—Epirubicin—liver cancer	0.000639	0.00074	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—liver cancer	0.000633	0.000733	CcSEcCtD
Zolmitriptan—Vomiting—Epirubicin—liver cancer	0.000615	0.000712	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—liver cancer	0.000612	0.000709	CcSEcCtD
Zolmitriptan—Rash—Epirubicin—liver cancer	0.00061	0.000706	CcSEcCtD
Zolmitriptan—Dermatitis—Epirubicin—liver cancer	0.000609	0.000705	CcSEcCtD
Zolmitriptan—Headache—Epirubicin—liver cancer	0.000606	0.000701	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—liver cancer	0.000592	0.000685	CcSEcCtD
Zolmitriptan—Nausea—Epirubicin—liver cancer	0.000574	0.000665	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—liver cancer	0.000569	0.000658	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—liver cancer	0.000564	0.000653	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—liver cancer	0.000563	0.000652	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—liver cancer	0.00056	0.000649	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—liver cancer	0.000531	0.000615	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CG—liver cancer	7.96e-05	0.000651	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK14—liver cancer	7.93e-05	0.000649	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CSF2—liver cancer	7.9e-05	0.000647	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CG—liver cancer	7.79e-05	0.000638	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ESR1—liver cancer	7.78e-05	0.000636	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CD—liver cancer	7.7e-05	0.000631	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—F2—liver cancer	7.68e-05	0.000629	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CD—liver cancer	7.54e-05	0.000617	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APC—liver cancer	7.35e-05	0.000602	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CG—liver cancer	7.35e-05	0.000602	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADAM17—liver cancer	7.25e-05	0.000593	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTP1—liver cancer	7.23e-05	0.000592	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—liver cancer	7.13e-05	0.000584	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKCE—liver cancer	7.08e-05	0.000579	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CD—liver cancer	7e-05	0.000573	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCE—liver cancer	6.93e-05	0.000567	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BRAF—liver cancer	6.91e-05	0.000566	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CD—liver cancer	6.85e-05	0.000561	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—F2—liver cancer	6.83e-05	0.000559	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSMD10—liver cancer	6.81e-05	0.000558	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSMA4—liver cancer	6.81e-05	0.000558	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CB—liver cancer	6.71e-05	0.00055	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF2—liver cancer	6.7e-05	0.000549	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.67e-05	0.000546	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTM1—liver cancer	6.64e-05	0.000544	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CB—liver cancer	6.57e-05	0.000538	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—liver cancer	6.56e-05	0.000537	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CG—liver cancer	6.54e-05	0.000535	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CD—liver cancer	6.46e-05	0.000529	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PIK3CA—liver cancer	6.4e-05	0.000524	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SERPINE1—liver cancer	6.39e-05	0.000523	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—KRAS—liver cancer	6.33e-05	0.000518	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1A1—liver cancer	6.3e-05	0.000515	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CSF2—liver cancer	6.26e-05	0.000512	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RAF1—liver cancer	6.25e-05	0.000511	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—F2—liver cancer	6.2e-05	0.000508	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—H2AFX—liver cancer	6.17e-05	0.000505	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2—liver cancer	6.17e-05	0.000505	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLUL—liver cancer	6.15e-05	0.000504	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CPT1B—liver cancer	6.15e-05	0.000504	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CSF2—liver cancer	6.13e-05	0.000502	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RAF1—liver cancer	6.12e-05	0.000501	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CB—liver cancer	6.1e-05	0.000499	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—H2AFX—liver cancer	6.04e-05	0.000494	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2—liver cancer	6.04e-05	0.000494	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CB—liver cancer	5.97e-05	0.000489	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CG—liver cancer	5.94e-05	0.000486	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NR1H4—liver cancer	5.93e-05	0.000486	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—liver cancer	5.87e-05	0.000481	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA3—liver cancer	5.83e-05	0.000478	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PIK3CA—liver cancer	5.81e-05	0.000476	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAF1—liver cancer	5.77e-05	0.000472	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARA—liver cancer	5.76e-05	0.000471	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CD—liver cancer	5.75e-05	0.00047	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CB—liver cancer	5.63e-05	0.000461	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MTOR—liver cancer	5.63e-05	0.000461	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—liver cancer	5.6e-05	0.000458	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TERT—liver cancer	5.58e-05	0.000457	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—liver cancer	5.48e-05	0.000449	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TERT—liver cancer	5.46e-05	0.000447	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—HRAS—liver cancer	5.38e-05	0.00044	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA4—liver cancer	5.34e-05	0.000437	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1B—liver cancer	5.29e-05	0.000433	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCE—liver cancer	5.28e-05	0.000432	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—liver cancer	5.23e-05	0.000428	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CD—liver cancer	5.22e-05	0.000427	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.22e-05	0.000427	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA2—liver cancer	5.2e-05	0.000426	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—liver cancer	5.18e-05	0.000424	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—liver cancer	5.17e-05	0.000423	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—liver cancer	5.15e-05	0.000421	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—liver cancer	5.1e-05	0.000418	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK14—liver cancer	5.07e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—liver cancer	5.04e-05	0.000413	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JUN—liver cancer	5.03e-05	0.000412	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTA1—liver cancer	5.02e-05	0.000411	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CB—liver cancer	5.01e-05	0.00041	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—liver cancer	5e-05	0.000409	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—liver cancer	5e-05	0.000409	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNB1—liver cancer	4.99e-05	0.000409	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ESR1—liver cancer	4.97e-05	0.000407	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK14—liver cancer	4.96e-05	0.000406	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NAT2—liver cancer	4.96e-05	0.000406	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—liver cancer	4.93e-05	0.000404	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—F2—liver cancer	4.91e-05	0.000402	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—liver cancer	4.9e-05	0.000401	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1A—liver cancer	4.88e-05	0.000399	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—liver cancer	4.87e-05	0.000399	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—F2—liver cancer	4.81e-05	0.000394	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.77e-05	0.00039	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK8—liver cancer	4.76e-05	0.00039	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—liver cancer	4.76e-05	0.00039	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDOB—liver cancer	4.76e-05	0.000389	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—liver cancer	4.75e-05	0.000389	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APC—liver cancer	4.7e-05	0.000385	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—liver cancer	4.7e-05	0.000385	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSF2—liver cancer	4.67e-05	0.000382	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAF1—liver cancer	4.66e-05	0.000381	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APC—liver cancer	4.6e-05	0.000377	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—liver cancer	4.6e-05	0.000377	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—H2AFX—liver cancer	4.6e-05	0.000377	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—liver cancer	4.6e-05	0.000376	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—liver cancer	4.55e-05	0.000372	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CRABP1—liver cancer	4.54e-05	0.000371	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—liver cancer	4.42e-05	0.000362	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—liver cancer	4.4e-05	0.00036	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—liver cancer	4.35e-05	0.000356	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—liver cancer	4.34e-05	0.000355	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—liver cancer	4.33e-05	0.000354	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—liver cancer	4.28e-05	0.00035	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—liver cancer	4.18e-05	0.000342	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—liver cancer	4.16e-05	0.000341	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—liver cancer	4.13e-05	0.000338	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—liver cancer	4.09e-05	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—liver cancer	4.09e-05	0.000335	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.09e-05	0.000334	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—liver cancer	4.05e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—liver cancer	4.05e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—liver cancer	4.04e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—liver cancer	4.04e-05	0.00033	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—liver cancer	4.01e-05	0.000328	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—liver cancer	4e-05	0.000328	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HPGDS—liver cancer	3.97e-05	0.000325	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—liver cancer	3.96e-05	0.000324	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.94e-05	0.000323	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—liver cancer	3.81e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK14—liver cancer	3.78e-05	0.000309	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—liver cancer	3.78e-05	0.000309	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—liver cancer	3.74e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—liver cancer	3.72e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—liver cancer	3.71e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAF1—liver cancer	3.69e-05	0.000302	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—F2—liver cancer	3.66e-05	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—liver cancer	3.64e-05	0.000298	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAF1—liver cancer	3.61e-05	0.000296	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTOR—liver cancer	3.6e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—liver cancer	3.6e-05	0.000295	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.59e-05	0.000294	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.55e-05	0.00029	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMD10—liver cancer	3.54e-05	0.000289	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMA4—liver cancer	3.54e-05	0.000289	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—liver cancer	3.53e-05	0.000289	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTOR—liver cancer	3.53e-05	0.000289	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APC—liver cancer	3.51e-05	0.000287	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—liver cancer	3.51e-05	0.000287	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—liver cancer	3.44e-05	0.000281	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GOT2—liver cancer	3.44e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—liver cancer	3.43e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1B—liver cancer	3.38e-05	0.000277	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—liver cancer	3.37e-05	0.000276	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—liver cancer	3.34e-05	0.000274	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—liver cancer	3.32e-05	0.000272	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—liver cancer	3.31e-05	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1B—liver cancer	3.31e-05	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—liver cancer	3.31e-05	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—liver cancer	3.3e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—liver cancer	3.29e-05	0.000269	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—liver cancer	3.27e-05	0.000268	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—liver cancer	3.24e-05	0.000266	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—liver cancer	3.24e-05	0.000265	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2E1—liver cancer	3.23e-05	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—liver cancer	3.22e-05	0.000264	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—liver cancer	3.22e-05	0.000264	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—liver cancer	3.22e-05	0.000263	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNB1—liver cancer	3.19e-05	0.000261	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—liver cancer	3.18e-05	0.00026	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—liver cancer	3.16e-05	0.000258	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—liver cancer	3.15e-05	0.000258	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—liver cancer	3.13e-05	0.000256	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.13e-05	0.000256	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNB1—liver cancer	3.13e-05	0.000256	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1A—liver cancer	3.12e-05	0.000255	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—liver cancer	3.08e-05	0.000252	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—liver cancer	3.07e-05	0.000251	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1A—liver cancer	3.05e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—liver cancer	3.05e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—liver cancer	3.05e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK8—liver cancer	3.04e-05	0.000249	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—liver cancer	3.04e-05	0.000249	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—liver cancer	3.04e-05	0.000249	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYCS—liver cancer	3.03e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—liver cancer	3.02e-05	0.000247	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK8—liver cancer	2.98e-05	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—liver cancer	2.97e-05	0.000243	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GOT1—liver cancer	2.97e-05	0.000243	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GGT1—liver cancer	2.97e-05	0.000243	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—liver cancer	2.81e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—liver cancer	2.81e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—liver cancer	2.78e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—liver cancer	2.77e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—liver cancer	2.75e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAF1—liver cancer	2.75e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—liver cancer	2.73e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTOR—liver cancer	2.69e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—liver cancer	2.69e-05	0.00022	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—liver cancer	2.67e-05	0.000218	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—liver cancer	2.63e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—liver cancer	2.59e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—liver cancer	2.58e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—liver cancer	2.57e-05	0.00021	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—liver cancer	2.53e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—liver cancer	2.53e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1B—liver cancer	2.52e-05	0.000206	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—liver cancer	2.49e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—liver cancer	2.47e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—liver cancer	2.47e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—liver cancer	2.46e-05	0.000201	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—liver cancer	2.45e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—liver cancer	2.41e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—liver cancer	2.4e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—liver cancer	2.39e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNB1—liver cancer	2.38e-05	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—liver cancer	2.34e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—liver cancer	2.34e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1A—liver cancer	2.33e-05	0.00019	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1A1—liver cancer	2.32e-05	0.00019	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—liver cancer	2.3e-05	0.000189	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK8—liver cancer	2.27e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—liver cancer	2.27e-05	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—liver cancer	2.2e-05	0.00018	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—liver cancer	2.17e-05	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—liver cancer	2.15e-05	0.000176	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARA—liver cancer	2.12e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—liver cancer	2.12e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—liver cancer	2.1e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—liver cancer	2.08e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—liver cancer	2.08e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—liver cancer	2.03e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—liver cancer	1.99e-05	0.000163	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—liver cancer	1.94e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—liver cancer	1.93e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—liver cancer	1.92e-05	0.000158	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.91e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—liver cancer	1.9e-05	0.000156	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—liver cancer	1.88e-05	0.000154	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—liver cancer	1.82e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—liver cancer	1.79e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—liver cancer	1.78e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—liver cancer	1.76e-05	0.000144	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—liver cancer	1.76e-05	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—liver cancer	1.64e-05	0.000134	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—liver cancer	1.6e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—liver cancer	1.58e-05	0.00013	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—liver cancer	1.58e-05	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—liver cancer	1.52e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—liver cancer	1.45e-05	0.000119	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—liver cancer	1.39e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—liver cancer	1.34e-05	0.00011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—liver cancer	8.5e-06	6.96e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—liver cancer	6.94e-06	5.68e-05	CbGpPWpGaD
